Wealthgarden F.S. LLC Novo Nordisk A S Transaction History
Wealthgarden F.S. LLC
- $107 Billion
- Q4 2024
A detailed history of Wealthgarden F.S. LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealthgarden F.S. LLC holds 2,730 shares of NVO stock, worth $218,809. This represents 0.22% of its overall portfolio holdings.
Number of Shares
2,730
Previous 3,974
31.3%
Holding current value
$218,809
Previous $473 Million
50.37%
% of portfolio
0.22%
Previous 0.46%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.6 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.24 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.04 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.01 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$978 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $181B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...